Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium

Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium

Arc Bio today launched its GalileoTM Pathogen Solution (GPS) product line at the ASM Clinical Virology Symposium (CVS) in Savannah. With this announcement comes the Early Access commercial release of the first product in the GPS line: GPS-Transplant. GPS-Transplant is a comprehensive next-generation sequencing (NGS) test providing data to aid in the monitoring of post-transplant patients who are at high risk for infection or reactivation of potentially fatal viral infections.

With the current standard of real-time quantitative PCR (qPCR) technology, only one virus can be detected per test, despite there being hundreds of different viral strains that can infect transplant patients. GPS-Transplant is one comprehensive test able to detect the most common viral infections among transplant patients – including Cytomegalovirus (CMV), Epstein–Barr virus (EBV), BK virus (BKV) and human adenovirus (hADv) – and their variances and genotypes, as well as rarer infections. GPS-Transplant offers the ability to detect antiviral resistance mutations, coupled with simultaneous quantitative detection of greater than 350 viral strains.

GPS-Transplant will initially be made available as a Research Use Only test that laboratories can purchase and validate in their own laboratories as a Laboratory Developed Test.

At a workshop at CVS on enabling NGS-based metagenomics in the clinical virology laboratory, Benjamin Pinsky, MD, PhD, Medical Director of Clinical Virology at Stanford Healthcare & Stanford Children’s Health, will present data from his study of GPS-Transplant in immunocompromised patients.

My team observed near perfect agreement between samples quantified by both qPCR and the Galileo Pathogen Solution. By using Galileo my team was also able to identify a number of viruses that were not initially tested by the clinical teams.”

Benjamin Pinsky, MD, PhD, Medical Director of Clinical Virology at Stanford Healthcare & Stanford Children’s Health

Data from two additional studies will also be presented at CVS. “The ability to transform metagenomic data into a titer and compare accurately with singleplex qPCR assays is outstanding and completely novel in this field,” said Judith Breuer, MD, Professor of Virology at University College London and Honorary Consultant Virologist at Great Ormond Street Hospital for Children NHS Trust, whose team will present one of these studies. “We have used metagenomics for the past two years in my laboratory, the development and introduction of which was relatively complex and time consuming. Arc Bio’s out-of-the-box concept certainly brings advantages to laboratories who wish to evaluate this cutting-edge technology but who don’t have the expertise to do this alone.”

The number of transplants in the U.S. is growing by approximately 4% yearly, and of the more than 57,000 transplants each year, about 30% of all recipients will get a viral infection. The average cost to treat a viral infection from a donor organ or reactivation post-transplant per patient is about $400,000.

When we mapped out our suite of NGS-based metagenomics research solutions under the GalileoTM product family, we felt it was important to first help laboratories address areas of greatest need. Transplantation was an obvious candidate, where the frequency of infection, along with associated costs and stress on patients and families, is high. Towards that end, we focused on delivering an integrated solution to provide valuable information relating to the viral status in post-transplant patients. We are very pleased to now make this powerful viral monitoring solution commercially available for research use only to laboratories around the world. Going forward, the Galileo line of products will continue to grow as we further expand menu and functionality to include broader patient populations.”

Arc Bio Chief Executive Officer Dr. Todd Dickinson

Galileo Pathogen Solution provides healthcare professionals with a research tool that gives them the power to perform sophisticated pathogen analyses without requiring bioinformatics expertise. It is a sample-to-report solution built around the Illumina NGS platform that consists of reagents, built-in assay controls, and Galileo Analytics, a cloud-based proprietary software that provides quick and reliable results, an intuitive user interface, and detailed, actionable reports. Galileo Analytics leverages Arc Bio’s highly curated pathogen database (ArcIve) and also incorporates the best-in-class Galileo AMR resistance prediction technology launched in 2018.

Tagged with:

About author

Related Articles